GWW
43
2
NEE
59
2
PEG
41
5
CFG
95
2
AVGO
38
-4
WU
18
-2
ABT
47
2
HAS
63
-8
ILMN
49
4
SHW
62
-2
AON
69
2
ORLY
54
-11
WY
56
12
HST
58
3
PRU
65
11
CAG
19
-4
V
44
-2
NSC
53
2
EL
56
4
EXR
37
4
GWW
43
2
NEE
59
2
PEG
41
5
CFG
95
2
AVGO
38
-4
WU
18
-2
ABT
47
2
HAS
63
-8
ILMN
49
4
SHW
62
-2
AON
69
2
ORLY
54
-11
WY
56
12
HST
58
3
PRU
65
11
CAG
19
-4
V
44
-2
NSC
53
2
EL
56
4
EXR
37
4
Financhill
Back

Neurogene Stock Predictions

7 Stocks to Consider Immediately (must-see chart)

See the green days for 7 major stocks right here, free of charge
Sell
39

NGNE
Neurogene

Last Price:
$22.00
Seasonality Move:
7.37%

7 Day Trial

ALL ACCESS PASS

$ 7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks

Click Here to Download Your FREE Stock Report Now

Neurogene Stock Forecast

  • Over the next 52 weeks, Neurogene has on average historically risen by 48.6% based on the past 11 years of stock performance.
  • Neurogene has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%
  • Is Neurogene Stock Undervalued?
    The current Neurogene [NGNE] share price is $21.96. The Score for NGNE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Neurogene Stock Go Up Next Year?

  • Over the next 52 weeks, Neurogene has on average historically risen by 48.6% based on the past 11 years of stock performance.

Neurogene Stock Rating

Sell
39
Neurogene (NGNE) is a Sell

Is Neurogene overpriced?

  • Neurogene has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%

Neurogene Stock Price History

Is NGNE stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NGNE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com

52-Week Data

52-Week High:
74.49
52-Week Low:
6.88

Prediction Charts

Market Cap:
313.2M
Price in USD:
21.96
Volume:
111.6K
Beta:
-1.21

Technical Analysis

SMA50:
18.02
SMA100:
16.24
SMA200:
24.31
52-Wk Change:
-43.05%

Stock Predictions

  • Is Neurogene stock public?
    Yes, Neurogene is a publicly traded company.
  • What is the Neurogene stock quote today?
    The Neurogene stock price is 21.96 USD today.
  • How to buy Neurogene stock online?
    You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-20 18.49 17.76 18.56 17.70
Jun-23 17.73 17.22 18.05 16.86
Jun-24 17.50 17.20 18.21 16.55
Jun-25 17.20 16.88 17.45 16.51
Jun-26 17.13 16.57 17.26 16.30
Jun-27 16.60 16.16 16.86 15.90
Jun-30 16.33 14.95 16.33 14.93
Jul-1 15.50 19.19 21.19 14.65
Jul-2 19.25 19.75 21.19 19.08
Jul-3 20.02 20.09 20.71 19.01
Jul-7 19.80 19.50 20.55 19.37
Jul-8 19.75 20.28 20.80 19.62
Jul-9 20.57 21.26 21.44 20.21
Jul-10 21.16 21.96 22.06 20.90

Neurogene Earnings

Neurogene Earnings Report: Per Share Neurogene Earnings Q1 Q2 Q3 and Q4 last year and next year.

Neurogene Forecast Revenue Growth

Neurogene Stock Analysis: Historical quarterly revenues per share for Neurogene and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.19 per share, a decrease this year of $0.51 per share, and a decrease next year of $0.93 per share.

* Neurogene stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.